Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print

Hyaluron Contract Manufacturing



Published March 15, 2007
Related Searches: Promotions & Moves
Hyaluron Contract Manufacturing (HCM) has promoted Paul Souza to the position of chief financial officer, with responsibility for all financial operations, including investor relations, at the privately-held company.

“Hyaluron has achieved a level of growth that entails more complex financial operations,” said company founder and president, Shawn Kinney.  “Among other things, we are looking to expand our investor base and felt it was imperative to have a man of Paul’s expertise and experience in the role of CFO.”
 
In 2006, the company reports that its revenues increased 68% over the previous year, for an average annual growth rate of 60% during the last three years.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On